A gain of function p53 mutant promotes both genomic instability and cell survival in a novel p53-null mammary epithelial cell model

FASEB Journal

Volumn 14, Issue 14, 2000, Pages 2291-2302

  Murphy, Kristen L ^a   Dennis, Andrew P ^a   Rosen, Jeffrey M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Aneuploidy; Apoptosis; Centrosome abnormalities; Mutant p53

Indexed keywords

MUTANT PROTEIN; PROTEIN P53;

ANEUPLOIDY; ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST EPITHELIUM; CARCINOGENESIS; CELL SURVIVAL; CENTROSOME; CONTROLLED STUDY; DNA DAMAGE; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ADENOVIRIDAE; ANIMALIA; MUS MUSCULUS;

EID: 0033747336     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.00-0128com     Document Type: Article

References (58)

1. p53, guardian of the genome
2. Genomic instability, in animal tumor-genesis models
3. The emerging p53 gene family
4. A genetic model for colorectal tumorigenesis
5. Mutations in the p53 gene in primary human breast cancer
6. Database of p53 gene somatic mutations in human tumors and cell lines; updated compilation and future prospects
7. Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients
8. Gain of function mutations in p53
9. Identification of p53 as a sequence-specific DNA binding protein
10. Oncogenic forms of p53 inhibit p53-regulated gene expression
11. Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation
12. Mutant p53 and genomic instability in a transgenic mouse model of breast cancer
13. Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis
14. Pathways of spindle pole formation: Different mechanisms; conserved components
15. Centrosome hypertrophy in human breast tumors: Implications for genomic stability and cell polarity
16. Centrosome amplification and a defective G2/M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells
17. The relationship of DNA ploidy to chromosomal instability of primary human colorectal cancers
18. A transgenic mouse model for mammary carcinogenesis
19. Tissue-specific, high-level expression of the rat whey acidic protein gene in transgenic mice
20. Neu/erbB-2 cooperates with p53 172H during mammary tumorigenesis in transgenic mice
21. Cooperative interaction between mutant p53 and des(1-3)IGF-1 accelerates mammary tumorigenesis
22. Development of mammary preneoplasias in vivo from mouse mammary epithelial cells in vitro
23. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
24. Genetic mechanisms of tumor suppression by the human p53 gene
25. Analysis of chicken progesterone receptor function and phosphorylation using adenovirus-mediated procedure for high-efficiency DNA transfer
26. The pCL vector system: Rapid production of helper-free, high titer, recombinant retroviruses
27. Developmentally and hormonally regulated CCAAT/enhancer-binding protein isoforms influence beta-casein gene expression
28. Involvement of BRCA2 in DNA repair
29. Abnormal centrosome amplification in the absence of p53
30. Supernumerary, centrosomes and cancer: Boveri's hypothesis resurrected
31. p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer
32. p53 modulation of TFIIH-associated nucleotide excision repair activity
33. Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage
34. Decreased DNA repair but normal apoptosis in ultraviolet-irradiated skin of p53-transgenic mice
35. 6-methylguanine-DNA methyltransferase (MGMT) by DNA damaging agents
36. p53 deficiency does not affect the accumulation of point mutations in a transgene target
37. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells
38. p53 is linked directly to homologus recombination processes via RAD51/RecA protein interaction
39. Illegitimate recombination leading to allelic loss and unbalanced translocation in p53-mutated human lymphoblastoid cells
40. Inactivation of p53 results in high rates of homologous recombination
41. Increase of spontaneous intrachromosomal homologous recombination in mammalian cells expressing a mutant p53 protein
42. Mutant p53 proteins stimulate spontaneous and radiation-induced intrachromosomal homologous recombination independently of the alteration of the transactivation activity and of the G1 checkpoint
43. Apoptosis, p53, and tumor cell sensitivity to anticancer agents
44. Comparative analysis of p73 and p53 regulation and effector functions
45. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage
46. Chromosome changes caused by alterations of p53 expression
47. Sister-chromatid exchanges: A report of the GENETOX program
48. Sister chromatid exchanges are mediated by homologous recombination in vertebrate cells
49. Normal meiotic recombination in p53-deficient mice
50. Sister chromatid exchange response of various human and mouse tissues to MMC and BrU
51. Requirement for the Xrcc1 DNA base excision repair gene during early mouse development
52. An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control
53. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy, and transformation
54. Deregulated cyclin E induces chromosome instability
55. Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts
56. Both viral (adenovirus E1B) and cellular (hsp70, p53) components interact with centrosomes
57. Mitosis in a cell with multiple centrioles
58. The mitotic machinery as a source of genetic instability in cancer